Population level survival of patients with chronic myelocytic leukemia in Germany compared to the US in the early 21st century

INTRODUCTION: The advent of tyrosine kinase inhibitors has produced 5-year survival of 90 + % for chronic myelocytic leukemia (CML) patients in clinical trials. However, population level survival has been lower, especially in older patients. Here, we examine survival of patients with CML in Germany...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Pulte, Dianne, Barnes, Benjamin, Jansen, Lina, Eisemann, Nora, Emrich, Katharina, Gondos, Adam, Hentschel, Stefan, Holleczek, Bernd, Kraywinkel, Klaus, Brenner, Hermann
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2013
Предметы:
Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3848850/
https://ncbi.nlm.nih.gov/pubmed/24499592
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-8722-6-70
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы